Schrödinger (NASDAQ: SDGR) is transforming drug discovery and materials research. Used by biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide, our software platform can predict critical properties of molecules before scientists embark on time-consuming and costly experiments. Schrödinger has also deployed its computational platform to advance its own drug discovery programs, as well as those of various pharmaceutical and biotec...